Cell-based approaches towards treating age-related macular degeneration.

Cell and Tissue Banking
Alireza Baradaran-RafiiBabak Arjmand

Abstract

Age-related macular degeneration as one of the most common causes of worldwide vision loss needs a proper approach for treatment. Therein, cell therapy and regenerative medicine can hold a great promise to be an effective approach. Accordingly, some preclinical and clinical studies were conducted to search around the therapeutic influence of stem cells in Age-related macular degeneration models and subjects. Hereupon, the purpose of the current review is to discuss the mechanisms of age-related macular degeneration, appropriate animal models along with suitable dosage and route of stem cell administration for its treatment.

References

May 1, 1988·Survey of Ophthalmology·N M BresslerS L Fine
Jan 1, 1983·Annals of the New York Academy of Sciences·J R Held
May 7, 2002·American Journal of Human Genetics·Ingo EbersbergerSvante Pääbo
Oct 21, 2003·Nature Medicine·Jayakrishna AmbatiBalamurali K Ambati
Mar 9, 2004·Genome Biology·Simon N Twigger
Mar 24, 2004·Brain Research Bulletin·Cheryl Rowe-Rendleman, Randolph D Glickman
Apr 25, 2007·The Journal of Medicine and Philosophy·Benjamin Djulbegovic
Jul 13, 2007·Genome Biology·Sean J HumphrayJane Rogers
Oct 24, 2007·Indian Journal of Ophthalmology·Salvatore Grisanti, Focke Ziemssen
Feb 5, 2008·American Journal of Ophthalmology·Elaine W-T ChongRobyn H Guymer
Jul 1, 2008·Photomedicine and Laser Surgery·Boris T Ivandic, Tomislav Ivandic
May 2, 2009·Annual Review of Genomics and Human Genetics·Anand SwaroopGonçalo R Abecasis
Apr 3, 2010·Human Molecular Genetics·N V StrunnikovaS S Miller
Apr 27, 2010·Annual Review of Biomedical Engineering·Biju Parekkadan, Jack M Milwid
Nov 9, 2010·The Veterinary Clinics of North America. Food Animal Practice·Sheldon Middleton
Sep 29, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jeffrey H Stern, Sally Temple
Dec 31, 2011·Stem Cell Research & Therapy·Rubens Camargo Siqueira
Jan 28, 2012·Lancet·Steven D SchwartzRobert Lanza
Apr 25, 2012·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Daniele VerittiPaolo Lanzetta
Jun 19, 2012·Molecular Aspects of Medicine·Mark E PennesiRobert J Courtney
Mar 26, 2013·Journal of Developmental Origins of Health and Disease·C Rabadán-Diehl, P Nathanielsz
Apr 20, 2013·Stem Cells Translational Medicine·David E BuchholzDennis O Clegg
Aug 31, 2013·Drug Design, Development and Therapy·F SemeraroC Costagliola
Jul 30, 2014·Frontiers in Aging Neuroscience·Kaushal SharmaAkshay Anand
Aug 21, 2014·International Journal of Molecular Sciences·Yuxi HeGuanfang Su
Jan 15, 2015·Experimental Eye Research·Qian JianZheng Qin Yin
Jun 27, 2015·Progress in Retinal and Eye Research·Hossein NazariMark S Humayun
Jun 3, 2016·Frontiers in Aging Neuroscience·Akshay AnandKeshava Prasad
Jul 20, 2016·Expert Opinion on Drug Delivery·Victor M VillegasHarry W Flynn
Jan 24, 2017·Progress in Retinal and Eye Research·Melissa K JonesShaomei Wang

❮ Previous
Next ❯

Citations

Jan 3, 2021·Cell and Tissue Banking·Bagher LarijaniBabak Arjmand
Apr 30, 2021·Carbohydrate Polymers·Xiaodan ZhangQiang Zhu

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Cell and Tissue Research
Steven Hatfield, Hannele Ruohola-Baker
Seminars in Cancer Biology
Paul C ParkJeremy A Squire
© 2021 Meta ULC. All rights reserved